207_Combined course Presentations

Oligometastatic NSCLC

 For patients with NSCLC and molecular mutations or rearrangements targeted with systemic therapy, metastatic progression frequently occurs in limited number and location

subgroup of patients who can enjoy significantly longer treatment responses and prolonged survival